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Introduction
Ribose-5-phosphate isomerases (Rpis) are essential enzymes in the pentose phosphate pathway and in the Calvin cycle of plants. Loss of Rpi activity in humans has been linked to the disease leukoencephalopathy (Huck et al., 2004) . Two evolutionary distinct forms of the enzyme, RpiA and RpiB, with different amino-acid sequences and molecular weights have been identified. Both forms catalyse the reversible conversion of ribose 5-phosphate to ribulose 5-phosphate ( Fig. 1 ). RpiA is found in the bacterial, plant and animal kingdoms, whereas RpiB is less widespread and is found in bacterial sources; genes encoding both enzymes are found in Escherichia coli (David & Wiesmeyer, 1970) . Crystal structures of RpiA have been reported for E. coli (Rangarajan et al., 2002; Zhang et al., 2003) , Plasmodium falciparum (Holmes et al., 2006) and Pyrococcus horikoshii (Ishikawa et al., 2002) . Proteins from the archaea Methanocaldococcus jannaschii have been targeted for high-throughput structure determination as part of the RIKEN Structural Genomics Initiative (Sugahara et al., 2008) . Here, we report the crystal structure of RpiA from M. jannaschii at 1.78 Å resolution.
Materials and methods

Cloning, expression and purification
The gene encoding MJ1603 (gi:15669799) was amplified via PCR using M. jannaschii DSM 2661 genomic DNA and was cloned into the pET-21a expression vector (Merck Novagen, Darmstadt, Germany). The expression vector was introduced into E. coli Rosetta (DE3) strain (Merck Novagen, Darmstadt, Germany) and the recombinant strain was cultured in 2.5 l LB medium containing 30 mg ml À1 chloramphenicol and 50 mg ml À1 ampicillin. The harvested cells (8.5 g) were lysed by sonication in 15 ml 20 mM Tris-HCl buffer pH 8.0 containing 500 mM NaCl, 5 mM -mercaptoethanol and 1 mM phenylmethylsulfonyl fluoride on ice. The cell lysate was heat-treated at 363 K for 12 min and centrifuged at 15 000g for 30 min at 277 K. The supernatant was desalted by fractionation on a HiPrep 26/10 column (GE Healthcare Biosciences). The sample was applied onto a Toyopearl SuperQ-650M column (Tosoh, Tokyo) equilibrated with 20 mM Tris-HCl buffer pH 8.0 and eluted with a linear NaCl gradient (0-0.4 M). The target sample, which eluted in the 0.34 M NaCl fraction, was desalted (HiPrep 26/10) and then applied onto a Resource Q column (GE Healthcare Biosciences) equilibrated with 20 mM Tris-HCl buffer pH 8.0 and eluted with a linear gradient of 0-0.4 M NaCl. The fractions that eluted in 0.34 M NaCl were further purified using a hydroxyapatite CHT20-I column (Bio-Rad Laboratories) with a linear gradient of 0.01-0.5 M potassium phosphate buffer pH 7.0. The target sample, which eluted in the 0.3 M potassium phosphate fraction, was concentrated and applied onto a HiLoad 26/60 Superdex 200 pg column (GE Healthcare Biosciences) equilibrated with 20 mM Tris-HCl buffer pH 8.0 containing 200 mM NaCl. The protein sample was analyzed by SDS-PAGE and was confirmed by N-terminal amino-acid sequencing. After concentration to 8 mg ml À1 by ultrafiltration, the protein yield was 44.5 mg from 8.5 g of cells.
Crystallization
Crystallization was performed by the microbatch-under-oil method at 291 K. 0.5 ml crystallization reagent, consisting of 0.1 M acetate pH 4.5 containing 40%(v/v) 1,2-propanediol and 0.05 M calcium acetate (Emerald Cryo I condition No. 21, Emerald BioSystems), was mixed with 0.5 ml 8.1 mg ml À1 protein solution. The mixture was then covered with 15 ml silicone and paraffin oil. Crystals suitable for X-ray data collection appeared within one week and reached final dimensions of 0.1 Â 0.07 Â 0.07 mm. The crystals were flash-cooled in a nitrogen-gas stream at 100 K without additional cryoprotectant.
Data collection and processing
Experiments were performed at the Daresbury Synchrotron Radiation Source (SRS) using the combined crystallography/X-ray absorption beamline 10.1, employing a Si(111) sagittally focused monochromator tuned to a wavelength of 1.074 Å . Diffraction data were recorded at 100 K from a single crystal. Images were recorded using a MAR Mosaic 225 CCD detector and were processed and scaled using HKL-2000 (Otwinowski & Minor, 1997) . The crystal was found to belong to space group P2 1 , with unit-cell parameters a = 54.86, b = 100.27, c = 80.46 Å , = 92.54 . Data-collection and processing parameters are shown in Table 1 .
Structure solution and refinement
Structure solution was accomplished by molecular replacement with MOLREP (Vagin & Teplyakov, 1997) using as a search model the RpiA tetramer from P. horikoshii (PDB code 1lk5; Ishikawa et al., 2002) obtained from the Protein Data Bank (Abola et al., 1987) . The search model has 52% identity and gave a molecular-replacement score and R factor of 0.43 and 54.6%, respectively (the next highest score and R factor were 0.26 and 60.3%, respectively). Following initial rounds of rigid-body and restrained refinement using REFMAC (Murshudov et al., 1997) , the structure was rebuilt with the correct amino-acid sequence using ARP/wARP (Perrakis et al., 1999) and REFMAC in combination with Coot (Emsley & Cowtan, 2004) . The R factor and R free of the final model to 1.78 Å resolution were 14.8% and 18.8%, respectively. The stereochemistry of the final model was checked using MolProbity (Davis et al., 2007) . The structure was deposited in the PDB under accession code 3ixq. The protein interfaces, surfaces and assemblies service PISA (Krissinel & Henrick, 2007) at the European Bioinformatics Institute (http:// www.ebi.ac.uk/msd-srv/prot_int/pistart.html) was used to explore the structural and chemical properties of the molecule. The topology and fold of a single subunit of M. jannaschii RpiA. (a) The topology diagram shows -helices represented as red cylinders, -strands as pink arrows and loops as blue lines. There are two domains and an interface region, which is made up of four -strands. The larger domain (domain I) contains four -helices, one 3 10 -helix and six -strands and includes both the C-terminal and N-terminal ends, while the smaller domain (domain II) contains two -helices and four -strands. The corresponding three-dimensional structure is shown in (b), with the secondary structure coloured according to topology and labelled according to the sequence. The topology diagram was obtained using the PDBSUM server (Laskowski, 2009 ). The molecular-graphics figures were all obtained using PyMOL (DeLano, 2008).
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Results and discussion
Size-exclusion chromatography shows that a tetramer is the most probable biological unit in the solution state, which is in agreement with the crystallographic data. Each subunit of the tetramer was modelled with only the first residue at the N-terminus missing from the electron-density map. The topology and fold of one subunit is shown in Fig. 2 . It comprises six -helices, one 3 10 -helix and 14 -strands divided into two domains, with domain I containing helices 1-4 and -strands 1-3, 6, 13 and 14, and domain II containing helices 5 and 6 and -strands 8-11. The remaining four -strands (4, 5, 7 and 12) form the interface between the two domains. The tetramer buries approximately 27% of the solvent-accessible surface area of each subunit. The residues involved in intersubunit interactions (Fig. 3 ), using subunit A as an example, include Arg161, Leu162, Asp164, Arg165, Lys166, Arg167 and Asp173, all of which are on the loop linking 9 and 10 in domain II, and Glu58 and Met64 on helix 3 and Gly100 on the loop linking 5 and helix 3, all of which belong to domain I. These residues make up to 13 hydrogen bonds or salt bridges with their symmetric counterparts in subunit B. The interface between subunits A and D is formed with 18 potential hydrogen bonds and salt bridges and involves the symmetrically related residues Ser142, Tyr144, Arg145 and Arg149, all of which are on helix 5 of domain II, and Leu73, Asp74, Tyr76 and Asp77, all of which are on the loop linking 3 and 3, and Gln105 on 4 of domain I. The interaction between subunits A and C is less extensive, burying only 4% of the surface area of each, comprising three hydrogen bonds and one salt bridge and involving the symmetrically equivalent residues Lys60 on helix 3 and Leu70, Asp74 and Glu75, all of which are in domain I. The biologically active assembly of RpiA in E. coli is a dimer (Essenberg & Cooper, 1975; Rangarajan et al., 2002) . The corresponding substructure of the M. jannaschii tetramer is identified as the dimer AD, giving an r.m.s.d. of 1.04 Å for 296 C atoms.
The active site is located at the interface between the two domains and the residues involved are known to be highly conserved among RpiA proteins from different sources. In M. jannaschii, each of the four subunits of the carbohydrate-binding pocket was found to contain two molecules of propylene glycol, which was used in the crystallization medium. The active site comprises residues from helix 2 and 4 of domain I and residues from the domain-interface -strands. The propylene glycol molecules are bound at the same location as that occupied by arabinose 5-phosphate, an inhibitor ligand found to bind at the active site in Cartoon representation of the RpiA tetramer. The major contacts in the tetramer, as described in the text, are between subunits AD and BC, which form dimers equivalent to the biologically functional dimer of RpiA in E. coli, and between subunits AB and CD. These interactions within the tetramer are clearly shown here by two orientations of the molecule related by a 90 rotation about the vertical axis. 1o8b; Zhang et al., 2003) . The propylene glycol molecule takes up two orientations at the active site (Fig. 4) . In the first of these it occupies a position corresponding to that of the phosphate moiety in the inhibitor ligand, in which it is has the potential to form hydrogen bonds to the backbone carbonyl group of Thr28 and the Lys97 and Glu106 side chains. The second binding site corresponds to the location of the furanose ring of the inhibitor, in which the propylene glycol hydroxyl groups can interact with both the Ser30 and Thr31 side-chain O atoms.
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